The yeast RGG motif-containing RNA binding protein Scd6 and its human ortholog LSM14A regulate the translation of specific ...

Bin Wu, associate professor in the department of Biophysics and Biophysical Chemistry at the School of Medicine, visited ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

Many lasso peptides show some amount of antimicrobial activity, but lariocidin is unique in that it kills bacteria by binding to the bacterial ribosome. Lariocidin binds to the aminoacyl site in ...

RNA vaccines train the immune system in a similar way to traditional vaccines, but they use a different strategy to get there.

The partnership’s main focus is on developing the nasally delivered mRNA vaccine targeting influenza. Credit: mi_viri/Shutterstock. Ethris has partnered with contract development and manufacturing ...

NEW YORK – The US Food and Drug Administration has cleared CureVac to begin a Phase I trial of its mRNA-based precision immunotherapy CVHNLC in patients with squamous non-small cell lung cancer, the ...

This normally requires a specific signal in the mRNA that guides the ribosome to override the stop and insert selenocysteine. In horses, no such signal was found in the KEAP1 transcript.

The United States led the world in developing the technology that beat the COVID-19 pandemic. Action from lawmakers may leave that legacy—and a $70 billion market—behind.